Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 34Colonic Neoplasms 18Rectal Neoplasms 14Pancreatic Neoplasms 8Esophageal Neoplasms 7Adenomatous Polyposis Coli 7Liver Neoplasms 5Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Turcot syndrome 2Thymoma 2Neoplasms 2Lung Neoplasms 2Locally Advanced Rectal Cancer 2Hand-Foot Syndrome 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Thrombocytosis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polyps 1Pancreatic Cancer Metastatic 1Pain, Postoperative 1

Interventions

Gemcitabine 3folfirinox 2Oxaliplatin 2Irinotecan 2toripalimab 1surufatinib 1sintilimab 1devimistat 1chloroquine diphosphate 1balstilimab 1Taxes 1Paclitaxel 1Leucovorin 1Injections 1Immune Checkpoint Inhibitors 1Drug Therapy 1Cisplatin 1Chloroquine 1Celecoxib 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Cancer Metastatic × Celecoxib × Gastrointestinal × Clear all
NCT06076837 2026-01-12

The Seven Trial: Exploiting the Unfolded Protein Response

HonorHealth Research Institute

Phase 1 Active not recruiting
6 enrolled
Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡